about
Vgamma1+ T cells and tumor necrosis factor-alpha in ozone-induced airway hyperresponsivenessA portable system for rapid bacterial composition analysis using a nanopore-based sequencer and laptop computer.Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway.Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammationEosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge.Empyema associated with Campylobacter curvus infection.Human bronchial smooth muscle cell proliferation via thromboxane A2 receptor.Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production.Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury.Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor.TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells.Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice.PAF responsiveness in Japanese subjects with plasma PAF acetylhydrolase deficiency.Mesenchymal Stem Cells Recruit CCR2+ Monocytes To Suppress Allergic Airway Inflammation.Effects of TNF-alpha-converting enzyme inhibition on acute lung injury induced by endotoxin in the rat.Endothelin-1 level in epithelial lining fluid of patients with acute respiratory distress syndrome.Activation of p70S6 Kinase-1 in Mesenchymal Stem Cells Is Essential to Lung Tissue Repair.Effect of cisplatin on H+ transport by H+ -ATPase and Na+/H+ exchanger in rat renal brush-border membraneRole of interleukin-6 in bleomycin-induced lung inflammatory changes in miceTargeting CXCR3 reduces ligand-induced T-cell activation but not development of lung allergic responsesRole of prostaglandin D2 and CRTH2 blockade in early- and late-phase nasal responses
P50
Q28387976-50A2E21F-44A4-41C5-BCD3-3D1EC7D99E63Q33916299-C525676A-6826-4FE1-8AF5-E0B36CBA4F38Q34049963-705C410F-FFF9-41CC-853F-A21597E42D3EQ34124817-E50E94F2-FE01-4961-88D2-25D35C387DC2Q36105237-E9880C5C-3422-4C41-8773-1B66C9DE2915Q40249181-D4FB8801-1222-42B0-B0E6-8439D0198423Q42171671-F6667964-522F-4692-B1AA-C5C85007D6C8Q43043816-F41CE84A-064D-4B9A-9CBC-927EFBDF3727Q43101826-FBCAFDB9-BDB5-424A-9EAA-568F3A63CD57Q45140717-96E5620B-5B6C-4432-8AE4-B563F44A6230Q46297781-DFD683E8-E310-4BFA-A9F3-742A81978380Q46555270-72863D70-6013-40C4-BE99-D4A83E6383DBQ46725968-A8486220-B885-494A-977A-A61EF98D9659Q48000951-46A905FD-A662-46B1-89CC-8C9AE0A5EB46Q48204969-959265C2-45C1-4A02-8FEC-EFEE77AB9981Q51762825-FD306BAD-3631-4B62-AF8E-AB53D08CA568Q53527310-EB0EA2F2-1BBF-4152-9299-B0A0A17B5D68Q54112157-499750E3-08A0-4D51-B538-AC54EF2B843EQ74210750-23961045-D48B-4783-9149-4E5DE552E73DQ80241537-924BA0A0-1F2B-4347-9FFB-CFFC795419E6Q84622198-48A78394-2B61-4F0F-BDF1-935AA9F65BEEQ87152423-49F939AD-E5A2-4AFB-9FA5-839D4E73D461
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yoshiki Shiraishi
@ast
Yoshiki Shiraishi
@en
Yoshiki Shiraishi
@es
Yoshiki Shiraishi
@sl
type
label
Yoshiki Shiraishi
@ast
Yoshiki Shiraishi
@en
Yoshiki Shiraishi
@es
Yoshiki Shiraishi
@sl
prefLabel
Yoshiki Shiraishi
@ast
Yoshiki Shiraishi
@en
Yoshiki Shiraishi
@es
Yoshiki Shiraishi
@sl
P1053
K-1015-2015
P106
P1153
8304467800
P31
P3829
P496
0000-0001-5275-6318